scholarly journals The response to double-dose hepatitis B vaccination in patients with HIV

2022 ◽  
Vol 8 (1) ◽  
pp. 31-36
Author(s):  
Melda TURKEN ◽  
Tuba TATLI KIŞ ◽  
Sabri ATALAY ◽  
Şükran KÖSE
Keyword(s):  
Hepatitis B ◽  
Hepatitis B Vaccination ◽  
Double Dose

scholarly journals Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list

2008 ◽  
Vol 12 (4) ◽  
pp. 306-309 ◽  
Author(s):  
Patricia R. Bonazzi ◽  
Telesforo Bacchella ◽  
Angela C. Freitas ◽  
Karina T. Osaki ◽  
Marta H. Lopes ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Liver Transplant ◽  
Waiting List ◽  
Hepatitis B Vaccination ◽  
Double Dose ◽  
Cirrhotic Patients ◽  
Liver Transplant Waiting List

Double-dose hepatitis B vaccination in people with HIV

2015 ◽  
Vol 15 (11) ◽  
pp. 1245-1246
Author(s):  
Nancy F Crum-Cianflone ◽  
Mark R Wallace
Keyword(s):  
Hepatitis B ◽  
Hepatitis B Vaccination ◽  
Double Dose

Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients

Vaccine ◽  
2020 ◽  
Vol 38 (24) ◽  
pp. 3995-4000 ◽  
Author(s):  
Jung-Hwan Lee ◽  
Seri Hong ◽  
Jae Hyoung Im ◽  
Jin-Soo Lee ◽  
Ji Hyeon Baek ◽  
...  
Keyword(s):  
Systematic Review ◽  
Immune Response ◽  
Hepatitis B ◽  
Meta Analysis ◽  
Hepatitis B Vaccination ◽  
Double Dose

scholarly journals A Double‐Dose Hepatitis B Vaccination Schedule in Travelers Presenting for Late Consultation

2014 ◽  
Vol 21 (4) ◽  
pp. 260-265 ◽  
Author(s):  
Jason Wong ◽  
Michael Payne ◽  
Susan Hollenberg
Keyword(s):  
Hepatitis B ◽  
Vaccination Schedule ◽  
Hepatitis B Vaccination ◽  
Double Dose

Comparing the Efficacy of Double Dose Hepatitis B Vaccine with Conventional Dose Hepatitis B Vaccine in CLD Patients

2021 ◽  
Vol 15 (8) ◽  
pp. 1861-1863
Author(s):  
Mohammad Hamid ◽  
Tahir Ullah Khan ◽  
Atif Masood ◽  
Faisal Amin Baig ◽  
Wali Khan ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis B ◽  
Chronic Liver Disease ◽  
Dose Group ◽  
Hepatitis B Vaccine ◽  
Chronic Liver ◽  
Hepatitis B Vaccination ◽  
Double Dose ◽  
Conventional Dose

Aim: To compare the efficacy of double dose hepatitis B vaccine with conventional dose hepatitis B vaccine in hepatitis C related chronic liver disease patients. Study design: Interventional study (randomized controlled clinical trial) Place and duration of study: Outpatient Department of Medicine, Services Hospital, Lahore from 12th August 2019 to 12th February 2020. Methodology: One hundred and ten patients of both male and female age group 30 to 70 years diagnosed with chronic liver disease on the basis of changed liver echo texture on ultrasound were included. Patients were divided into two groups, each group having 55 patients. One group was given double dose (2ml) while the other was given conventional dose (1ml). Both groups were compared for efficacy in terms of prevention of CLD. Results: The mean age of conventional group was 33.8±9.6 years while 33.7±9.1 years in the double dose group with male predominance (69.10%). Hypo-responsiveness was detected in 23.6% and 32.7% of conventional low dose group and double dose group respectively. There were gender variations in mean Anti-HBs levels. It was 129.80±70.53 mIU/mL in males and 113.26±75.57 mIU/mL in female patients (P= 0.039). Mean titers of anti-HBs in conventional dose group and high dose group were 127.82±67.59 mIU/mL and 121.56±77.00 mIU/mL, respectively (P= 0.52). Conclusion: Double dose hepatitis B vaccination in chronic HCV infected patients efficiently increases the response rate and hence protection against chronic hepatitis B. Keywords: Double dose hepatitis B vaccine, conventional hepatitis B vaccine, chronic hepatitis.

scholarly journals An investigation of the efficacy on hepatitis B vaccination in hemodialysis patients in Ardabil, Iran

2018 ◽  
Vol 8 (1) ◽  
pp. 6-10
Author(s):  
Susan Mohammadi Kebar ◽  
Saeed Hoseininia ◽  
Yousef Mohammadi Kebar ◽  
Mohammad Broumand
Keyword(s):  
Immune Response ◽  
Hepatitis B ◽  
Poor Response ◽  
Hemodialysis Patients ◽  
Hepatitis B Vaccine ◽  
Hepatitis B Vaccination ◽  
Double Dose ◽  
Serological Markers ◽  
The Past ◽  
Lower Immune Response

Introduction: Hemodialysis patients usually demonstrate lower immune response to hepatitis B vaccine compared to non-uremic population. Objectives: The present study aimed to determine the level of response to hepatitis B vaccination in patients under hemodialysis. Patients and Methods: This study was conducted on 172 live patients receiving hemodialysis in the dialysis department of Buali hospital in Ardabil, Iran (2015). To analyze their response to the vaccine, their vaccination titers were investigated. Before vaccination, the serological markers of hepatitis B and C were checked in all of the patients. Those for whom HBsAg and HBsAb results were negative and had not received the vaccinein the past entered the study. The patients received a double dose of hepatitis B vaccine at 0, 1, and 6 months after the beginning of dialysis. The response to the vaccine was investigated by measuring the level of patients’ hepatitis B antibody one month after receiving the last dose of the vaccine. Results: Seventy patients (40% of the total) displayed a proper immune response to the vaccine, 34 patients (19.8%) were without, and 68 patients (39.5%) were identified to have poor response. The results of Pearson’s correlation test indicated that there is a negative correlation between the patients’ age and their response to the vaccine. Conclusion: The results of this study indicated that higher age is one of the factors that reduce the effectiveness of hepatitis B vaccine in hemodialysis patients.

Compliance with a hepatitis B vaccination program

1984 ◽  
Vol 48 (10) ◽  
pp. 563-565
Author(s):  
HJ Kwon ◽  
KM Keenan ◽  
H Colman ◽  
KM Sundeen ◽  
DE Waite
Keyword(s):  
Hepatitis B ◽  
Vaccination Program ◽  
Hepatitis B Vaccination
Sign in / Sign up

Export Citation Format

Share Document